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Abstract
Background: Approximately 30% Australians suffer 
from arthritis and other musculoskeletal disorders. 
From 2003-2033 there is a predicted 223% increase in 
expenditure on health management of musculoskeletal 
disorders. There is evidence of increasing prevalence 
of orthopaedic complaints, in longer waiting lists for 
specialist consultations in public hospital outpatient 
clinics. Little is known about the costs and ramifications 
of waiting for orthopaedic consultations.
Aim: Establish what is known about the direct and 
indirect costs of being placed on a waiting list for an 
orthopaedic consultation.
Method: Patient and Outcome search strategy of 
Medline, Embase, Pubmed, NHS Economic evaluation 
database (NHS-EED) from each database inception date. 
Handsearching of reference lists of included papers also 
occurred. A realist synthesis framework underpinned 
the review, using a ubiquitous patient journey to map 
available literature on the impact of waiting. Hierarchy 
of evidence was reported using NHMRC criteria and 
articles critically appraised using either the PEDRo or 
CASP criteria (relevant to the design). A purpose-built 
data extraction instrument was developed.
Results: We identified 786 studies, of which 139 were 
relevant, including a systematic review (Hoogeboom et 
al) with 15 included articles which were added to the list 
of eligible papers (and the review itself deleted), leaving 
153 included articles; 17 were relevant to the review. 
Fourteen papers reported on quality of life and four 
reported on costs, two of these papers reported on both 
and all were of low to moderate quality. The research 
was not based on a comprehensive understanding 
of the stages of waiting, and there were inconclusive 
outcomes for quality of life and cost.
Conclusion: There is scant evidence of the impact on 
quality of life and costs of waiting for orthopaedic 
outpatient appointments. Future research should aim 
for improved methodological quality and use patient-
focused quality of life measures, and validated measures 
of cost.
Abbreviations: NHMRC – National Health and Medical 
Research Council; PROMS – Patient Related Outcome 
Measures; QoL – Quality of Life; WOMAC – Western 
Ontario and McMaster Universities Osteoarthritis 
Index; YLD – Years Lived With Disability.
Key words: Orthopaedics; waiting list; costs; scoping 
review.
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introduction
In May 2015, the Australian Institute of Health and Welfare 
(AIHW) reported that 28% of Australians (approximately 
6.1 million people), suffered from arthritis and other similar 
degenerative musculoskeletal disorders. [1] Moreover, 
musculoskeletal disorders were identified in 2010 as 
contributing 21.3% to worldwide years lived with disability 
(YLDs), this being second only to mental and emotional 
disorders. [2] Hip and knee osteoarthritis alone are reported 
to be the 11th highest contributor to global disability. 
[3] Gross explored predicted healthcare expenditure in 
Australia from 2003 to 2033, by disease. He documented 
a 223% anticipated increase in healthcare expenditure for 
musculoskeletal disorders, citing an ageing population 
and an increase in the incidence of disease as key drivers 
for escalating costs. [4] The increasing prevalence of 
orthopaedic conditions has been noted since as escalating 
use of hospital outpatient orthopaedic services, [5] 
particularly noticeable for individuals who require public 
health system management. [6,7,8,9] One way of managing 
the increasing volume of individuals requiring orthopaedic 
consultations in the public sector is to place them on 
waiting lists. In Australia there are two avenues for accessing 
healthcare, including orthopaedic care, via the public health 
system or through private health facilities. The public health
system in relation to specialist orthopaedic care is fully 
funded through the Medicare system, therefore the patient 
is not required to pay anything for this care, including 
appointments and subsequent treatment (including 
surgery) and investigations. The public health facilities 
are managed at state level and therefore there state-by-
state variations in process, procedures and definitions are 
inevitable.
The private health system can be accessed in two ways: 
the patient can fully fund all aspects of care or if they have 
private health insurance they can seek reimbursement 
through their private fund. Invariably in private healthcare 
the patient is subject to out of pocket expenses regardless 
of their level of cover.
There is consistent evidence of increasing numbers of people 
on public hospital waiting lists for orthopaedic consultations, 
and lengthening waiting periods for orthopaedic/
musculoskeletal surgery. [10,11,12] Outpatients can wait for
months from first being placed on the hospital waiting 
list, to having their first orthopaedic consultation, and 
there is usually additional waiting time following that, 
for treatment to be provided. For some patients, the time 
delay between initial consultation and treatment could be 
12 or more months. [13] There is also increasing evidence 
that whilst waiting, patients incur significant out-of-pocket 
costs for formal or informal care, in order to manage their 
condition. [5] These costs are direct and indirect. Direct costs 
could include medication, GP appointments, accessing 
further tests, travel to appointments, loss of wages, allied 
health visits, formal care and home adaptations, whilst 
indirect costs may be in the form of lost time at work or 
informal care arrangements. [14,5] There are also potential 
societal impacts, in the form of use of government funded 
care (residential or home-based care), loss of tax revenue, 
social support and hospitalisation. [5] In addition to the 
economic burden of waiting there is the potential for health 
deterioration, altered capacity to perform usual activities of
daily living, and reduced capacity to be productive at 
home and/or in society. [15,16] Deterioration in health 
state associated with musculoskeletal disease is considered 
to impact on many facets of well-being, general health, 
physical, social and mental health, and as such, produces 
barriers to participation in daily activities. [5]
Health departments and public hospitals particularly in 
the United Kingdom and in Australia have been exploring 
alternative workforce models of care to meet the increasing 
need for health services for patients with chronic 
orthopaedic/musculoskeletal complaints. [17,18,8,19,11,20] 
This includes new pathways of care and changes in the 
traditional models of care within the health workforce. [7,21] 
A common alternative model of care is senior allied health 
professionals performing roles traditionally undertaken 
by specialist medical practitioners, for example a specialist 
physiotherapist assessing, diagnosing and managing 
patients referred to an orthopaedic consultant. The purpose 
of these initiatives is to streamline and optimise use of 
expensive medical consultant time, minimise time ‘wasted’ 
on waiting lists, and provide alternative earlier care options 
for patients instead of simply ‘waiting’. [7,8]
Patients attending outpatient orthopaedic clinics are 
usually referred by general medical practitioners, or from 
other outpatient clinics. Within Australia, public hospital 
orthopaedic specialist consultation is often the preferred 
pathway to care, particularly when patients do not have 
private health insurance. Most public hospital orthopaedic 
waiting lists reflect a range of orthopaedic conditions 
affecting lower and upper limb joints, and the spine. [20] 
Increasing numbers of patients on orthopaedic outpatient 
waiting lists mean longer wait time for most people, [11] 
and potentially greater costs.
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This paper reports on a systematic scoping review of the 
literature undertaken with the aim of identifying what has 
been written about the costs of waiting (both direct and 
indirect) and the ramifications of waiting on quality of life 
(QoL).
Methods
Study design: A systematic scoping review of the 
international peer-reviewed literature was undertaken to 
identify the amount and type of research published in this 
area, and provide the first known evidence scan of what has 
been published to date on the cost and quality of life impact 
of waiting for an orthopaedic consultation.
Review registration: This review was registered with 
PROSPERO (CRD42016047332). PROSPERO is an international 
database used to register systematic reviews prior to the 
review being commenced. The purpose of PROSPERO is to 
provide a comprehensive list of systematic reviews in which
the key characteristics of the review are permanently 
recorded to avoid repetition and reporting bias.
Reporting standard: This review was reported in line 
with the Joanna Briggs Institute methodology for scoping 
reviews. [22] This provides a rigorous framework in the 
planning, development, study selection, collation of results 
and reporting to ensure that the most information is gleaned 
from the search and reported in a systematic, reproducible 
way.
Review purpose: The purpose of this review was to 
systematically identify and classify all freely available, 
relevant peer-reviewed literature which reported on the 
impact of waiting for consultation/treatment for patients 
with an orthopaedic/musculoskeletal complaint.
Framework of the review: We undertook this review within 
the context of a usual patient journey through the outpatient 
orthopaedic consultation process. This framework was 
based on a Realist Synthesis approach [23] which assists 
systematic review findings to be mapped for complex 
situations. Defining a waiting list is one such complex 
situation. To establish the realist synthesis framework, we 
undertook an informal overview of the literature about the 
orthopaedic outpatient journey, and found that there is a 
growing body of literature over the last decade on waiting 
list management. We constructed a map of the literature 
which reports on aspects of patient journeys (entering, 
being on, and leaving, an orthopedic outpatient waiting 
list). We proposed a ubiquitous patient journey (Figure 1) 
which outlines our understanding of the stages of waiting. 
This journey was used as an aid to describing the relevance
of the literature identified in this review, to aspects of the 
journey.
Search strategy: The search was conducted in March 2016 
and updated in September 2016. A PO search strategy 
(Participants, Outcomes) was applied to identify relevant 
articles. Library databases of Medline, Embase, Pubmed, and
NHS Economic evaluation database (NHS-EED) were 
Figure 1. Realist synthesis framework of ubiquitous patient journey
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Table 1: Search terms 
P  Orthopedics/musculoskeletal/orthop?edic*
I  Outpatient*/Ambulatory Care/clinic visit*
 Surgery/ treatment AND
 Waiting Lists/or wait*
C  Not relevant
O  cost*/Cost Control/Cost Sharing/ Cost-Benefit  
 Analysis/Cost Savings/ Cost of Illness/ Cost  
 Analysis
 Quality of life/function* status/ productivity/ 
 work/sick leave
S  No restriction on the study design
Exclusions  Inpatients, not Orthopaedic/musculoskeletal  
 patients, paediatric
 Conference papers and abstract only
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searched, from each database inception date. Broad 
search terms and inclusion criteria were applied in an 
attempt to identify all relevant papers related patients 
with an orthopaedic/musculoskeletal complaint waiting 
for specialist consultation/treatment. MESH headings 
or Boolean operators were used with the search terms, 
relevant to the database being searched. The search terms 
are outlined in Table 1.
Additional searching: The reference lists of the papers 
identified through the database searches were hand- 
searched to identify additional papers which were relevant, 
but which had not been identified from the literature search.
Population: Adult patients (18 years and over) with an 
orthopaedic and/or musculoskeletal complaint for which 
they had been referred to an outpatient clinic for specialist 
consultation/ treatment. No limitations were applied in 
terms of diagnostic categories.
Outcomes: Impact of waiting was explored in terms of 
cost, such as a costbenefit analysis, to the patient (in terms 
of productivity, loss time from work, direct health costs 
incurred), healthcare providers (visits to GPs, hospitalisations, 
community care) and society (loss of tax revenue) and the 
impact on the patient’s quality of life, function and social 
integration.
Study identification: The titles and abstracts of each 
potentially relevant paper were screened by two researchers 
(JM, AT) for relevance to the study purpose. In the case of 
dispute, a third author (KG) arbitrated.
Eligible studies: Studies of any hierarchy of evidence 
were considered for inclusion as long as they met the P 
and O criteria, and were in English language. Thus studies 
were included if they explored any impact of waiting 
for orthopaedic/musculoskeletal consultation and/or 
treatment for adults.
Exclusion criteria: Articles were excluded if they did not 
report on the impact of waiting for management of an 
orthopaedic/musculoskeletal complaint by a specialist, if 
they described children (younger than 18 years), if they did 
not report on quality of life and/or cost impacts, were not 
available in full text, and were not in English.
Hierarchy of evidence: Hierarchy of evidence was reported 
using National Health and Medical Research Council 
(NHMRC) criteria relevant to the study question. [24] This 
provides a comprehensive and structure way of grading 
evidence according to the research design. We anticipated 
that most studies would be classified using the aetiology 
hierarchy, as they would be largely observational (what 
happened as a result of waiting). The NHMRC evidence 
hierarchy is subdivided into five areas that mean the 
grading system is adaptable to different research questions, 
aetiology hierarchy refers to studies that explore causation 
of diseases or conditions.
Critical appraisal: This was undertaken by two independent 
reviewers using the relevant appraisal tool. Any level 
II studies were critically appraised with Physiotherapy 
Evidence Database [25] criteria, and the Level III-3 and IV 
studies were critically appraised with the Critical Appraisal 
Skills Program (CASP). [26] Critical appraisal scores were 
compared, and disagreements discussed and resolved.
Data extraction: Data was extracted by two reviewers 
working together (JM, AT). Data was extracted into a custom-
built MS Excel sheet to allow for easy comparison between 
the outcomes from the extracted studies. Extracted data 
included country of research, patient demographics, health 
condition, study design, waiting list description, where in 
the patient journey the research was conducted (see Figure 
1), measures of quality of life or cost. Cost data was further 
reported as types of cost.
Results
The search identified 786 potentially eligible studies (see 
Figure 2). There were 393 duplicates, and another 254 
articles were removed, after considering title and abstract, 
as not meeting the inclusion criteria. This left 139 potentially
relevant articles.
Handsearching: Included in these potentially relevant 
articles was a systematic review [27] which summarised 15 
primary articles. After debate, it was decided that, as aims 
of our review differed from the Hoogeboom et al aims, we 
should consider the 15 individual papers in the Hoogeboom 
review, rather than the review itself. [27] No other relevant 
references were identified from handsearching the 
remaining included papers’ reference lists.
Search results: The search output was adjusted from 139 
potentially relevant papers (including Hoogeboom et al) 
to 138 papers (excluding the Hoogeboom review) plus the 
15 component papers from the Hoogeboom et al review, 
giving 153 potentially relevant papers. Using the Pawson 
realist synthesis framework (Figure 1) to map the reported 
outcomes from the potentially relevant papers identified 17 
papers which met the review’s inclusion criteria (excluding 
135).
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•  There were two included papers which reported on  
 both costs and quality of life; March et al; Fielden et al.  
 [28,29]
•  The 13 included papers that reported only on quality 
 of life measures included Ackerman et al; Ahmas and  
 Konduru; Chakravarty et al; Desmeules et al; Desmeules  
 et al; Hirvonen et al; Kapstad et al; Kelly et al; McHugh 
 et al; Nilsdotter and Lohmander; Nunez et al; Ostendorf  
 et al; Pace et al. [31-41,16]
•  The two included papers that reported only on costs  
 comprised Rolfson et al and Tuominen et al. [14,42]
Hierarchy and quality of evidence: The included studies 
when graded according to the NHMRC hierarchy of evidence, 
demonstrated that the research in this area is generally low-
level aetiology studies, and III-3 uncontrolled prospective 
studies (see Table 2) and therefore of relatively low quality. 
Table 2 also reports critical appraisal scores.
Data descriptions
Countries where research was conducted: The studies 
were from a wide range of developed world countries 
(Canada, Finland, Australia, Holland, Spain, New Zealand, 
Sweden, Norway and the United Kingdom). None came 
Records identified through Medline, 
Embase, Pubmed, NHS Economic 
Evaluation databases (n= 786)
Papers assessed by full text for eligibility
(n=139) (adjusted to 153 papers 
by addition of the 15 component papers 
in Hoogeboom et al 2009 (SR) and 
removal of Hoogeboom et al
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or quality of life measures during any aspect 
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Included in scoping review N=17
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Records screened by title and abstract 
(n=393)
Additional articles identified through 
hand searching reference lists 
of included articles (n=10)
Excluded as not reporting on outcomes 
related to costs, or quality of life, whilst 
waiting N=137 (inc 5 components studies 
in Hoogeboom et al 2009)
Excluded as not meeting inclusion 
criteria (n=254)
Papers reporting quality of life measures 
N=15
Reporting on any element of costing 
N=4
Papers reporting on both relevant cost 
and quality of life measures  N=2
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from developing countries. Whilst all countries in the studies 
have established healthcare systems, there were significant 
differences between them in terms of how healthcare was 
delivered. This constrained comparison of findings.
Study periods: There was wide variability in the periods of 
research, the majority reported a 12-18 month recruitment 
of patients, whilst some recruited for over three years. 
Mapping the data against the realist synthesis ubiquitous 
patient journey (outlined Figure 1), there was a lack of 
consistency in the period of time over which data was 
collected making comparison of findings difficult. Figure 3 
outlines the included papers against the realist synthesis 
patient journey.
Musculoskeletal conditions: The included studies reported 
only on patients with osteoarthritis of the hip or knee, 
in particular there is a significant emphasis on patients 
awaiting total hip and knee replacements, and the period 
following surgery. In terms of the patients included in the 
reported studies, one striking issue is the lack of standardised 
measures used to add patients to the surgical waiting 
list. Only two papers [38,39] described a standardised 
grading system for severity of joint disease, one using the 
Table 2: Aetiology hierarchy 
QUALITY OF LIFE PAPERS  NHMRC  CRITICAL APPRAISAL – PEDRO 
   CASP COHORT TOOL
Desmeules et al 2010a  III-3  12/14  N/A
Desmeules et al 2010b  III-3  12/14  N/A
Hirvonen et al 2009  II  N/A  8/11
Ackerman et al 2011  III-3  12/14  N/A
Ostendorf et al 2004 III-3  11/14  N/A
Fielden et al 2005  III-3  9/14  N/A
Nunez et al 2006  III  N/A  7/11
March et al 2002  III-3  9/14  N/A
Ahmas & Konduru 2007  III-3  6/14  N/A
Chakravarty et al 2005  IV  9/14  N/A
Kapstad et al 2007  III-3  11/14  N/A
Kelly et al 2001  III-3  13/14  N/A
McHugh et al 2007  III-3  13/14  N/A
Nilsdotter & Lohmander 2002  III-3  11/14  N/A
Pace et al 2006  III-3  12/14  N/A
 COsT PAPERs  CRiTiCAL APPRAisAL – PEDRO
   CAsP ECOnOMiC TOOL
Tuominen et al 2009  II  N/A  8/11
March et al 2002  III-3  9/14  N/A
Fielden et al 2005  III-3  9/14  N/A
Rolfson et al 2012  III  9/14  N/A
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Kellgren-Lawrence grading system [43,44] and the other the 
Osteoarthritis Research Society International criteria whilst 
the remaining papers only reported that the patients had 
severe enough arthritis to warrant a joint replacement.
Waiting times: This was described variably, particularly 
what was considered to be long, medium and short term 
waiting periods and at what time points in the waiting 
period the measures are taken. Again the realist synthesis 
framework outlined in Figure 1 assisted in the comparison 
between studies. Fifteen papers explored the impact of the 
pre-operative waiting period on the outcome of surgery in 
some cases up to twelve months post-surgery. Only two 
papers [14,41] reported on the waiting period from point 
of GP referral into the specialist service. For the remaining 
papers, the start of the waiting period was deemed to be at 
the point the patient was placed on a surgical waiting list 
for a total hip or total knee replacement, depending on the 
study. See Figure 3.
Quality of life: Table 3 reports of the different quality of 
life measures reported in the included papers. The most 
commonly reported outcome measures were Short Form 
(36) Health Survey (SF-36) [45] and the Western Ontario and
McMaster Universities Osteoarthritis Index (WOMAC). 
[46] There were inconsistent findings about the impact of 
Figure 3: Papers across the spectrum of waiting
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Table 3: Quality of life outcome measures reported
 Quality of Country  year  Body  Sf36  WoMaC  WoMaC of   eQ-15 d Modified oxford KeSSler HrQol eQ-5 d aMeriCan
 life StudieS   Part   Contralatera   HarriS HiP PSyCHologiCal iteM  Knee
       l Knee  HiP SCore diStreSS inStruMentS  SoCiety 
         SCore  SCale   SCale
                
1  Desmeules Canada  2006-7  Knee 3	 3	 3	 7	 7	 7	 7	 7	 7	 7 
 et al 2010a  
2  Desmeules Canada  2006-7  Knee 3	 3	 3	 7	 7	 7	 7	 7	 7	 7
 et al 2010b  
3  Hirvonen Finland  2002-3 Hip 7	 7	 7	 3	 3	 7	 7	 7	 7	 7
 et al 2009  
4  Ackerman Australia  2002-5 Hip &
 et al 2011    knee 7	 7	 7	 7	 7	 7	 3	 3	 7	 7
5 Ostendorf Holland Apr 1997 Hip
 et al 2004   Sept 2000 awaiting 3	 3	 7	 7	 7	 7	 7	 7	 7	 7
    THR
6 Nunez et al Spain Feb-Oct Knee 3	 3	 7	 7	 7	 7 7	 7	 7	 7 
 2006 Spain  2001 awaiting
    TKR
7 Fielden et New Apr 1997- Hip 7	 3	 7	 7	 7	 7	 7	 7	 3	 7
 al 2005 Zealand Mar 2002 awaiting
    THR
8  March et al Australia 1994-95 Hip & 3	 3	 7	 7	 7	 7	 7	 7	 7	 7
 2002    knee  
9  Ahmad & UK June 2003- Knee 7	 3	 7	 7	 7	 7	 7	 7	 7	 7
 Konduru  Dec 2004
10  Chakravarty UK Unknown Hip 7	 3	 7	 7	 7	 7	 7	 7	 7	 7
 et al 2005 
11  Kapstad   Norway June 2003- Hip & 3	 3	 7	 7	 7	 7	 7	 7	 7	 7
 et al 2007  June 2004 Knee
12 Kelly et al Canada  Dec 1995- Hip & 3	 3	 7	 7	 7	 7	 7	 7	 7	 7
 2001  Jan 1997 Knee 
13  McHugh et al  UK  May-Nov Hip & 3	 7	 7	 7	 7	 7	 7	 7	 7	 7 
 2006  2003 Knee
14  Nilsdotter & Sweden  Feb 1997- Hip & 3	 7	 7	 7	 7	 7	 7	 7	 7	 7
 Lohmander  Oct 1998 Knee 
 2002  
15 Pace et al UK  Jan 2000-  Knee 7	 7	 7	 7	 7	 7	 7	 7	 7	 7
 2005  May 2003
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waiting on QoL. Two studies reported that some patients 
have improvements in their symptoms whilst waiting for 
surgery, [30,32] whilst four studies reported no change for 
some patients [36,32,35,38] whilst five studies reported 
worsening QoL. [16,33,30,37,41]
What is also unclear is which patients are likely to deteriorate 
and which are likely to stay the same or improve. Knapstad 
et al reported deterioration in stiffness and physical function 
in those patients awaiting a total knee replacement, in their 
study patients who were married/cohabiting demonstrated
greater deterioration than those who were single/widowed, 
no other predisposing factors for deterioration could 
be established. [35] There is some evidence [31,32] that 
younger patients will deteriorate faster than older patients.
There was also evidence to suggest that the length of wait 
pre-operatively negatively impacts on recovery operatively 
in terms of pain, function and QoL. [16,33]
Cost information: Table 4 reports the cost information 
recorded in the included papers reported under the broad 
categories of healthcare costs, community costs, informal 
care costs and society costs.
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Table 4: Cost parameters reported
 PaPer Country  year  Body  HealtHCare CoStS  CoMMunity CoStS PerSonal exPenSeS/ ProduCtiVity loSS
    Part   inforMal Care  
     PHarMa- HealtH-  teStS HoSPital tranS- HoMe HoMe      
     CeutiCal Care  Care Port & HelP Modif-
           iCationS
1  Fielden New  Apr 1999-  Hip 3	 7	 7	 7	 7	 7	 7	 Private expense paid	 	Time away
 et al 2005  Zealand Mar 2002 waiting        for medical care (user   from work
    THR        charges, privately  or casual
            funded care, travel  activity
            costs and paid help)
2  Rolfson Sweden Oct 2005-  Hip 3	 GP visit	 7	 Hospital Transport	 3	 3	 Value of  Value of	 Disability Sick leave 
      physio-  in ward for   lost leisure time away pension
      therapy  care disabled   by from work
            caregivers by 
             caregivers
3  Tuominen Finland  Aug 2002- Hip 3	 7	 7	 7		 7	 7	 7	 7	 7	 7	 7
 et al 2009   Nov 2003
4  March Australia  1994-99 Hip & 3	 Health 3 Hospital- Com- 7	 7	 Private	 7	 7	 7
 et al 2011    knee Prescribed	 profession	 	 isation	 munity	 	 	 services
     and non- at visits   services
     prescribed
Discussion
This paper presents the first known synthesis of information 
on the impact of waiting for orthopaedic care for 
musculoskeletal complaints, in terms of costs and quality 
of life. This review found a moderate amount of relevant 
literature (17 studies), reported mostly in prospective 
observational or descriptive studies, of low to moderate 
quality. There was interest from the developed world in 
assessing the impact of waiting, as evidenced by research 
produced in nine countries. This scoping review found little 
information on the impact of waiting that could assist in 
understanding how waiting on an outpatient orthopaedic 
waiting list impacted on the health system, the individual 
or society. The papers included in the review reported 
heterogeneous information on the patient journey, the costs 
measured whilst waiting and QoL of patients whilst waiting.
Orthopaedic conditions: The literature focused entirely on 
osteoarthritic hips and knees, and all studies were about 
patients waiting for surgery. The focus on hips and knees 
possibly reflects the high prevalence of these conditions on
public hospital waiting lists, the high cost of these joint 
replacements, the high prevalence of these conditions in 
the sociodemographics of people who require the public 
hospital system, and the orientation that this places on 
current research. [1,4,5] Thus there are many gaps in current 
knowledge regarding the impacts of waiting for individuals 
suffering other orthopaedic/musculoskeletal complaints.
Realist synthesis approach: The Realist Synthesis approach 
[23] was helpful in assisting us to understand just where in 
the patient journey, the included research focused. Without 
this approach, it would have been more difficult to scope 
the research findings. A key finding from investigating 
QoL in this scoping review was that all but one paper (with 
the exception of Pace et al [41]) was focused on one time 
period in the patient journey, that being from the point 
of being placed on a surgical waiting list to varying points 
postoperatively (one, three, six and twelve months following 
surgery) (See Figure 3). This constrained a useful synthesis 
of information on impact of waiting, and highlighted the 
need for greater understanding of the stages of waiting 
before further research is undertaken. If the most costly or 
impactful stages of waiting can be identified, interventions 
to avert long waiting times in these priority stages of the 
patient journey can be developed and tested.
Alternative models of care: This body of literature did not 
inform current thinking about substitution of care (such as 
extended scope practice, or alternative treatment options 
(such as conservative care). Whilst there is some evidence 
that these alternative models of care reduce waiting times 
and are satisfactory to patients, [8,47,48] what is unclear is 
how effective they are in terms of impact on quality of life 
and cost parameters.
Quality of life: 80% articles included in this review reported 
on QoL. The findings were inconclusive regarding changes 
in QoL whilst outpatients waited for an orthopaedic 
The Cost of Waiting on an Orthopaedic Waiting List: a scoping review
50 Asia Pacific Journal of Health Management 2017; 12: 2
appointment, or for treatment. QoL can be used as a point 
in time measure, or an over-time measure. [49] Therefore 
the ability to track change in QoL over time is an important 
function of any QoL outcome instrument employed in 
waiting list research. The two QoL measures reported in this 
review were WOMAC and SF36.
•  The WOMAC is disease specific, and is one of the most  
 commonly-used outcome measures in arthritis research,  
 particularly for osteoarthritis of the hip and knee. [46]  
 WOMAC is a self-reported instrument with five items for
 scoring pain, two for stiffness and 17 for functional  
 limitation. Functional tasks include stair use, standing  
 up from sitting, getting in and out of the car, shopping,  
 putting on and taking off socks, bending and walking.  
 WOMAC has been widely translated and validated in  
 other languages, although mainly for hip and knee  
 arthritis. [50] Whilst WOMAC has been tested for  
 conditions other than OA hip and knee, this is less  
 common and therefore less is known about its validity  
 for other musculoskeletal conditions. [50] The WOMAC  
 instrument has been shown to be less sensitive to  
 detecting change over time in some intervention-based  
 studies. [51,52,53,54] It is proposed that the rigid nature  
 of the questions may impact on sensitivity to change,  
 particularly when compared with more open-ended  
 measures. [51]
• The SF36 is a broadQoL measure, estimating health  
 status in domains of vitality, physical functioning, bodily  
 pain, general health perceptions, physical role  
 functioning, emotional role functioning, social function
  and mental health. [45] It has been widely used in  
 research internationally, on many different health  
 conditions to evaluate individual patient’s health status  
 and compare this to population norms, research the
 cost-effectiveness of treatments, and monitor and  
 compare disease burdens. However Kean et al observed  
 that it may not be sufficiently sensitive to change and
  thus its validity for use in research into the impact of  
 waiting is questionable. [55]
To better understand the subtleties of the impact of 
waiting on an individual’s QoL, it may require engagement 
with the notion of Patient Related Outcome Measures 
(PROMs). [56,57] To date, PROMs have been used to assess 
effectiveness of care. Safety and patient experience (such 
as shared decision-making, dignity, respect, comprehensive 
communication) have been less well explored. [57,58] 
These outcome elements may well reflect the subtleties 
of impact of waiting on QoL and thus there appears to be 
room for sophisticated patient-directed outcome measures 
to be developed that capture individual patient experiences 
whilst waiting for orthopaedic care.
Costs: There was a small body of literature (four studies only) 
which reported on costs. Measures of cost included health, 
community, personal and societal costs, and productivity. 
Costs were measured in a variety of ways including cost 
diary, retrospective reflections of costs incurred whilst 
waiting, and purpose-built questionnaires. None of the 
studies used independent validation of these costs, for 
example there was no formal comparison with pharmacy 
receipts or with Medicare data sets. Only one paper reported 
sufficient data to inform an economic analysis of costs and 
benefits. [14] It was therefore not possible to synthesise the 
information on costs whilst waiting, and thus this scoping 
review highlighted this as a significant area for further 
research.
Conclusion
This scoping review highlighted scant and inconsistent 
evidence regarding the impact of waiting on cost and QoL 
measures, for an orthopaedic outpatient appointment. The 
information that is available comes from a limited patient 
group (hip and knee osteoarthritis). There was little evidence 
of the impact of waiting across the continuum of the waiting 
period, as studies focused on sections of the patient journey. 
There was no clarity regarding how the waiting time in a 
patient’s journey could be considered, and the bulk of the 
literature focused on the time from when the patient is placed 
on the waiting list for hip or knee replacement surgery to the 
point of surgical intervention and subsequent rehabilitation. 
This means that little is currently known what went before 
the decision-making about the need for surgery. This review 
highlighted that there is little known about other types of 
patients referred for surgical consultation whose ultimate 
management is not surgery, or who proceed to surgery 
for a condition other than osteoarthritis of the hip or knee. 
Further research is required, using sensitive and defensible 
measures of QoL, and costs, before an understanding of the 
impact of waiting occurs, and before health systems can 
support healthcare providers to make shared and informed 
choices with their patients about the best management of 
orthopaedic complaints.
Future
Areas for improvement in future studies which assess the 
impact of waiting for specialist orthopaedic opinion are:
•  Broadening the focus of research to other types of  
 orthopaedic conditions. At this time the evidence  
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 focuses on patient with hip and knee osteoarthritis
 that are awaiting surgical intervention. Nothing was  
 found in this review about the impact of waiting for  
 specialist consultation and/or care for patients with  
 other musculoskeletal conditions (e.g. shoulder pain,  
 ankle problems, spinal pain and wrist/hand and elbow  
 problems).
•  Improving capture of QoL and cost outcomes. Standard  
 agreement is required regarding the most appropriate  
 and sensitive measures across a broad range of  
 musculoskeletal conditions to capture the impact of  
 waiting.
  For QoL, PROMs should be considered, as well as new  
  outcome measures to capture subtle individual  
  concerns, particularly in measuring individual concerns  
  about having to wait for attention for a condition that  
  may be worsening.
  For costs, valid measures of productivity costs,  
  opportunity costs, societal costs and healthcare costs  
  incurred by both the patient and the healthcare  
  system are required.
•  Increasing understanding of the phases of ‘waiting’.  
 Waiting is not simply about the time between the  
 orthopaedic decision and proceeding to surgery.  
 It includes the time between consulting a GP, being  
 placed on an outpatient waiting list, and then waiting  
 for an orthopaedic consultation. In the literature that is  
 available there is a lack of consistency in the measures  
 used to report the impact of waiting, in terms of both  
 cost and health outcomes/QoL. In particular the  
 different time points at which the impact of waiting  
 is measured across the different studies, makes  
 comparing outcomes problematic.
Key findings
Little is known about the impact of waiting for an 
orthopaedic specialist assessment. What evidence is 
available is of low hierarchy and low to moderate quality. 
Standardised measures of QoL and cost are required, as is 
a better appreciation of the waiting period, and the phases 
within it.
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